Search results for " board"

showing 10 items of 178 documents

Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria

2013

In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into nationwide disease-specific first-line clinical trials or interim registries. Essential components are a pediatric cancer registry and centralized reference laboratories, imaging review, and tumor board assistance. The five-year overall survival rate in countries where such infrastructures are established has improved from 80% since 1995. Today, treatment intensity is tailored to the individual patient's risk to provide the highest chances of survival while minimizing deleterious late effects. Multicenter clinical trials are internationalized and serve as platforms for further improvements by novel drugs an…

medicine.medical_specialtyPediatricsbusiness.industryChildhood cancerHematologyPediatric cancerClinical trialOncologyInterimScale (social sciences)Pediatrics Perinatology and Child HealthTreatment intensitymedicineOverall survivalTumor boardIntensive care medicinebusinessPediatric Blood & Cancer
researchProduct

Primary malignant PEComa of the mandible. Report of an unusual case

2021

Malignant PEComa is a rare entity that usually origins at visceral, retroperitoneal and abdominopelvic sites. In the present paper, we describe an extremely unusual manifestation of malignant PEComa involving the mandible in a 48 years-old female patient focusing on the anatomopathological findings and differential diagnosis. The therapeutic management based on the head and neck tumor board indications is also discussed. Key words:Malignant PEComa, PEComa of the mandible, PEComa pathology, Oral cavity unusual neoplasm.

medicine.medical_specialtyUnusual caseOral Medicine and Pathologybusiness.industryMandibleRare entityCase ReportFemale patientmedicineTumor boardRadiologyDifferential diagnosisbusinessHead and neckGeneral DentistryUNESCO:CIENCIAS MÉDICASJournal of Clinical and Experimental Dentistry
researchProduct

Biomarker testing of lung cancer in Spain

2019

Abstract Background Target therapy guide by biomarkers have become the standard of care for patients with lung cancer (LC). So, identify those molecular alterations is one of the most important care needs nowdays. Our objective was to know the implementation degree of these tests in a large cohort of patients in Spain using the Thoracic Tumor Registry (TTR) of the Grupo Espanol de Cancer de Pulmon (Spanish Lung Cancer Group). Methods The TTR is an observational cohort multicenter study of LC in Spain. The study is conducted according to the Declaration of Helsinki and approved by the institutional review board of each participating institute. The registry was approved by the Spanish Drug Ag…

medicine.medical_specialtybusiness.industryCancerHematologymedicine.diseaseInstitutional review boardHelsinki declarationClinical trialOncologyInternal medicineCohortmedicineBiomarker (medicine)Lung cancerbusinessGeographic differenceAnnals of Oncology
researchProduct

Tobacco use in lung cancer (LC) patients (p) in Spain

2019

Abstract Background Tobacco use, mainly as cigarette smoking, is the leading cause of lung cancer. Eighty-five percent of LC occur in smokers. Understanding the Spanish smoking habits allows the government to design health care policies against this consumption. To do so, the Grupo Espanol de Cancer de Pulmon (Spanish Lung Cancer Group) made this analysis within the context of the Thoracic Tumor Registry (TTR). Methods The TTR is an observational cohort multicenter study in Spain. The study is conducted according to the Declaration of Helsinki and approved by the institutional review board of each participating site. The registry was approved by the Spanish Drug Agency, as a non-post-author…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentContext (language use)Hematologymedicine.diseaseInstitutional review boardHelsinki declarationClinical trialOncologyFamily medicineCohortmedicineSmoking cessationLung cancerbusinessGeographic differenceAnnals of Oncology
researchProduct

Tumor Board and Molecular Tumor Board

2021

Specialized expertise and cooperation between different professional figures are increasingly needed for the management of cancer patients. Tumor boards (TB) can address this issue by gathering together different healthcare providers to periodically discuss challenging cases.

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicineTumor boardCancerMedical physicsMultidisciplinary teammedicine.diseasebusinessHealthcare providersTargeted therapy
researchProduct

The GALAD Score as Potential Screening Test for Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis: An International Multicenter Study

2019

The prevalence of nonalcoholic steatohepatitis (NASH) is rising rapidly and is currently the most common chronic liver disease in Western populations. Hepatocellular carcinoma (HCC) is a major complication of NASH and the current performance of screening approaches based on ultrasound shows limitations. To facilitate earlier diagnosis, this international multicenter study, with eight German and one Japanese center participating, tests the potential benefit of applying the biomarkers AFP, AFP-L3, DCP and related scores for HCC screening in NASH patients. In the retrospective German cohort, 126 NASH patients with newly diagnosed HCC and 231 NASH control patients without HCC were enrolled. In …

medicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationInstitutional review boardmedicine.diseaseChronic liver diseasedigestive system diseasesHelsinki declarationMulticenter studyInternal medicineHepatocellular carcinomaCohortMedicineAFP-L3businesseducationneoplasmsSSRN Electronic Journal
researchProduct

Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma

2016

Purpose To compare whole-body MRI (WB-MRI) with diffusion-weighted imaging (DWI), FDG-PET/CT, and bone marrow biopsy (BMB), for the evaluation of bone marrow involvement (BMI) in patients with newly diagnosed lymphoma. Materials and Methods This retrospective study was approved by our Institutional Review Board. Two independent radiologists and one nuclear medicine specialist reviewed all WB-MRI and FDG-PET/CT scans prospectively performed on 104 patients with newly diagnosed lymphoma (53 males; 47 Hodgkin; mean age: 44 years; range, 15–86 years) between 2013 and 2015. The delay between imaging scans and BMBs was up to 10 days. The diagnostic accuracy of WB-MRI (1.5 Tesla MR scanner, with T…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryMagnetic resonance imagingRetrospective cohort studyNewly diagnosedmedicine.diseaseInstitutional review board030218 nuclear medicine & medical imagingLymphoma03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureCohen's kappa030220 oncology & carcinogenesisBiopsyMedicineRadiology Nuclear Medicine and imagingBone marrowRadiologybusinessNuclear medicineJournal of Magnetic Resonance Imaging
researchProduct

Le commissioni di ricorso nel sistema di giustizia dell'Unione europea

2020

Le commissioni di ricorso nel diritto dell’Unione europea sono organi amministrativi, incaricati di risolvere controversie nei settori di competenza degli Uffici, Agenzie ed Autorità presso cui sono strutturate. Esercitano una sicura attività giustiziale, rafforzata dal carattere del loro intervento, che è pregiudiziale rispetto all’ordinaria tutela giurisdizionale. L’interesse per il tema è determinato anche dall’orientamento della giurisprudenza, esaminato nel volume. È invero prevalsa l’interpretazione della c.d. “continuità funzionale”, secondo cui le commissioni di ricorso svolgerebbero la stessa attività degli organi di prima istanza, accentuando gli aspetti amministrativi, a discapit…

nature of Board of AppealSettore IUS/14 - Diritto Dell'Unione Europeanature of Board of Appeal; art. 58 bis Statue of The Court of Justice; Court according to the art. 6 ECHRart. 58 bis Statue of The Court of JusticeCourt according to the art. 6 ECHR
researchProduct

Le Currency board : les contraintes de financement et d'ajustement de la convertibilité intégrale

2000

The paper scrutinizes the consequences of the adoption of a currency board arrangement (CBA) by some emerging economies during the 1990s. Considering the justifications o f this choice and the different setting-up contexts, it focuses on the implications of a CBA on the financial system and the real economy. A high degree of liquidity of the banking system is required in the absence of a lender-of-last-resort, and the automatic money supply process strictly disciplines the fiscal policy. Monetary stability is restored; but in most o f these economies where capital markets are underdeveloped, CBA's rules make the domestic credit supply dependent on the ability o f the economy to maintain ove…

politique monétairecontrainte d'ajustementbanque centralemonetary policyforeign exchange ratecurrency boardbase money[SHS.ECO]Humanities and Social Sciences/Economics and Financesupply of money and creditéconomies émergentesoffre de monnaietaux de change[ SHS.ECO ] Humanities and Social Sciences/Economies and financescaisse d'émission[SHS.ECO] Humanities and Social Sciences/Economics and Financebase monétaireemerging economiescentral bank
researchProduct

"Kansamme kykyyn itse arvostella ei voi luottaa!" : taidelautakunnat valtiollisina asiantuntijaeliminä ennen toista maailmansotaa

2012

public actiontaidehallintovallankäyttökulttuurijärjestötnationtaideyhdistyksethistorialautakunnattaide-elämäälymystösocietiesvertaisarviointi (arviointimenetelmät)asiantuntijatvaltiontukikulttuuriSuomiasiantuntijuusnationalismihistorical sociologykulttuuripolitiikkakorporativismiart boardskansalaisyhteiskuntaculturetaidealapublic spheretaidepolitiikkataidekäsityksethistoriallinen sosiologiaexpertisekansallisvaltiotaiteen tukeminenpoliticstaiteet1900-1939corporatism1800-lukuvalta
researchProduct